Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1989 Jun;52(Suppl):39–54. doi: 10.1136/jnnp.52.suppl.39

Transplantation into the human brain: present status and future possibilities.

O Lindvall 1
PMCID: PMC1033308  PMID: 2666578

Full text

PDF
39

Images in this article

45Image
on p.45
44Image
on p.44
46Image
on p.46

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agid Y., Javoy F., Glowinski J. Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. Nat New Biol. 1973 Oct 3;245(144):150–151. doi: 10.1038/newbio245150a0. [DOI] [PubMed] [Google Scholar]
  2. Arbuthnott G., Dunnett S., MacLeod N. Electrophysiological properties of single units in dopamine-rich mesencephalic transplants in rat brain. Neurosci Lett. 1985 Jun 12;57(2):205–210. doi: 10.1016/0304-3940(85)90064-3. [DOI] [PubMed] [Google Scholar]
  3. Backlund E. O., Granberg P. O., Hamberger B., Knutsson E., Mårtensson A., Sedvall G., Seiger A., Olson L. Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J Neurosurg. 1985 Feb;62(2):169–173. doi: 10.3171/jns.1985.62.2.0169. [DOI] [PubMed] [Google Scholar]
  4. Bakay R. A., Barrow D. L., Fiandaca M. S., Iuvone P. M., Schiff A., Collins D. C. Biochemical and behavioral correction of MPTP Parkinson-like syndrome by fetal cell transplantation. Ann N Y Acad Sci. 1987;495:623–640. doi: 10.1111/j.1749-6632.1987.tb23705.x. [DOI] [PubMed] [Google Scholar]
  5. Bakay R. A., Fiandaca M. S., Barrow D. L., Schiff A., Collins D. C. Preliminary report on the use of fetal tissue transplantation to correct MPTP-induced Parkinson-like syndrome in primates. Appl Neurophysiol. 1985;48(1-6):358–361. doi: 10.1159/000101157. [DOI] [PubMed] [Google Scholar]
  6. Bankiewicz K. S., Plunkett R. J., Kophin I. J., Jacobowitz D. M., London W. T., Oldfield E. H. Transient behavioral recovery in hemiparkinsonian primates after adrenal medullary allografts. Prog Brain Res. 1988;78:543–549. doi: 10.1016/s0079-6123(08)60329-5. [DOI] [PubMed] [Google Scholar]
  7. Barbeau A., Roy M., Cloutier T., Plasse L., Paris S. Environmental and genetic factors in the etiology of Parkinson's disease. Adv Neurol. 1987;45:299–306. [PubMed] [Google Scholar]
  8. Barker C. F., Billingham R. E. Immunologically privileged sites. Adv Immunol. 1977;25:1–54. [PubMed] [Google Scholar]
  9. Barry D. I., Kikvadze I., Brundin P., Bolwig T. G., Björklund A., Lindvall O. Grafted noradrenergic neurons suppress seizure development in kindling-induced epilepsy. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8712–8715. doi: 10.1073/pnas.84.23.8712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Becker J. B., Freed W. J. Neurochemical correlates of behavioral changes following intraventricular adrenal medulla grafts: intraventricular microdialysis in freely moving rats. Prog Brain Res. 1988;78:527–533. doi: 10.1016/s0079-6123(08)60327-1. [DOI] [PubMed] [Google Scholar]
  11. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci. 1973 Dec;20(4):415–455. doi: 10.1016/0022-510x(73)90175-5. [DOI] [PubMed] [Google Scholar]
  12. Bing G. Y., Notter M. F., Hansen J. T., Gash D. M. Comparison of adrenal medullary, carotid body and PC12 cell grafts in 6-OHDA lesioned rats. Brain Res Bull. 1988 Mar;20(3):399–406. doi: 10.1016/0361-9230(88)90069-x. [DOI] [PubMed] [Google Scholar]
  13. Björklund A., Dunnett S. B., Stenevi U., Lewis M. E., Iversen S. D. Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res. 1980 Oct 20;199(2):307–333. doi: 10.1016/0006-8993(80)90692-7. [DOI] [PubMed] [Google Scholar]
  14. Björklund A., Gage F. H. Grafts of fetal septal cholinergic neurons to the hippocampal formation in aged or fimbria-fornix-lesioned rats. Ann N Y Acad Sci. 1987;495:120–137. doi: 10.1111/j.1749-6632.1987.tb23671.x. [DOI] [PubMed] [Google Scholar]
  15. Björklund A., Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 1979 Nov 30;177(3):555–560. doi: 10.1016/0006-8993(79)90472-4. [DOI] [PubMed] [Google Scholar]
  16. Björklund A., Stenevi U., Schmidt R. H., Dunnett S. B., Gage F. H. Intracerebral grafting of neuronal cell suspensions. II. Survival and growth of nigral cell suspensions implanted in different brain sites. Acta Physiol Scand Suppl. 1983;522:9–18. [PubMed] [Google Scholar]
  17. Bohn M. C., Cupit L., Marciano F., Gash D. M. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science. 1987 Aug 21;237(4817):913–916. doi: 10.1126/science.2887034. [DOI] [PubMed] [Google Scholar]
  18. Brundin P., Barbin G., Strecker R. E., Isacson O., Prochiantz A., Björklund A. Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitro. Brain Res. 1988 Apr 1;467(2):233–243. doi: 10.1016/0165-3806(88)90027-2. [DOI] [PubMed] [Google Scholar]
  19. Brundin P., Björklund A. Survival, growth and function of dopaminergic neurons grafted to the brain. Prog Brain Res. 1987;71:293–308. doi: 10.1016/s0079-6123(08)61832-4. [DOI] [PubMed] [Google Scholar]
  20. Brundin P., Isacson O., Björklund A. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res. 1985 Apr 8;331(2):251–259. doi: 10.1016/0006-8993(85)91550-1. [DOI] [PubMed] [Google Scholar]
  21. Brundin P., Nilsson O. G., Strecker R. E., Lindvall O., Astedt B., Björklund A. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp Brain Res. 1986;65(1):235–240. doi: 10.1007/BF00243848. [DOI] [PubMed] [Google Scholar]
  22. Brundin P., Strecker R. E., Widner H., Clarke D. J., Nilsson O. G., Astedt B., Lindvall O., Björklund A. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp Brain Res. 1988;70(1):192–208. doi: 10.1007/BF00271860. [DOI] [PubMed] [Google Scholar]
  23. Brundin P., Widner H., Nilsson O. G., Strecker R. E., Björklund A. Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier. Exp Brain Res. 1989;75(1):195–207. doi: 10.1007/BF00248542. [DOI] [PubMed] [Google Scholar]
  24. Calne D. B., Duvoisin R. C., McGeer E. Speculations on the etiology of Parkinson's disease. Adv Neurol. 1984;40:353–360. [PubMed] [Google Scholar]
  25. Deckel A. W., Moran T. H., Coyle J. T., Sanberg P. R., Robinson R. G. Anatomical predictors of behavioral recovery following fetal striatal transplants. Brain Res. 1986 Feb 19;365(2):249–258. doi: 10.1016/0006-8993(86)91636-7. [DOI] [PubMed] [Google Scholar]
  26. Deckel A. W., Robinson R. G., Coyle J. T., Sanberg P. R. Reversal of long-term locomotor abnormalities in the kainic acid model of Huntington's disease by day 18 fetal striatal implants. Eur J Pharmacol. 1983 Sep 30;93(3-4):287–288. doi: 10.1016/0014-2999(83)90150-4. [DOI] [PubMed] [Google Scholar]
  27. Dick J. P., Cantello R., Buruma O., Gioux M., Benecke R., Day B. L., Rothwell J. C., Thompson P. D., Marsden C. D. The Bereitschaftspotential, L-DOPA and Parkinson's disease. Electroencephalogr Clin Neurophysiol. 1987 Mar;66(3):263–274. doi: 10.1016/0013-4694(87)90075-7. [DOI] [PubMed] [Google Scholar]
  28. Dunnett S. B., Björklund A., Schmidt R. H., Stenevi U., Iversen S. D. Intracerebral grafting of neuronal cell suspensions. IV. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiol Scand Suppl. 1983;522:29–37. [PubMed] [Google Scholar]
  29. Dunnett S. B., Björklund A., Schmidt R. H., Stenevi U., Iversen S. D. Intracerebral grafting of neuronal cell suspensions. V. Behavioural recovery in rats with bilateral 6-OHDA lesions following implantation of nigral cell suspensions. Acta Physiol Scand Suppl. 1983;522:39–47. [PubMed] [Google Scholar]
  30. Dunnett S. B., Björklund A., Stenevi U., Iversen S. D. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. II. Bilateral lesions. Brain Res. 1981 Dec 21;229(2):457–470. doi: 10.1016/0006-8993(81)91007-6. [DOI] [PubMed] [Google Scholar]
  31. Dunnett S. B., Björklund A., Stenevi U., Iversen S. D. Grafts of embryonic substantia nigra reinnervating the ventrolateral striatum ameliorate sensorimotor impairments and akinesia in rats with 6-OHDA lesions of the nigrostriatal pathway. Brain Res. 1981 Dec 14;229(1):209–217. doi: 10.1016/0006-8993(81)90759-9. [DOI] [PubMed] [Google Scholar]
  32. Dunnett S. B., Whishaw I. Q., Rogers D. C., Jones G. H. Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions. Brain Res. 1987 Jul 7;415(1):63–78. doi: 10.1016/0006-8993(87)90269-1. [DOI] [PubMed] [Google Scholar]
  33. Fiandaca M. S., Kordower J. H., Hansen J. T., Jiao S. S., Gash D. M. Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration. Exp Neurol. 1988 Oct;102(1):76–91. doi: 10.1016/0014-4886(88)90080-5. [DOI] [PubMed] [Google Scholar]
  34. Fine A., Hunt S. P., Oertel W. H., Nomoto M., Chong P. N., Bond A., Waters C., Temlett J. A., Annett L., Dunnett S. Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Prog Brain Res. 1988;78:479–489. doi: 10.1016/s0079-6123(08)60321-0. [DOI] [PubMed] [Google Scholar]
  35. Forno L. S. The Lewy body in Parkinson's disease. Adv Neurol. 1987;45:35–43. [PubMed] [Google Scholar]
  36. Freed W. J., Cannon-Spoor H. E., Krauthamer E. Intrastriatal adrenal medulla grafts in rats. Long-term survival and behavioral effects. J Neurosurg. 1986 Nov;65(5):664–670. doi: 10.3171/jns.1986.65.5.0664. [DOI] [PubMed] [Google Scholar]
  37. Freed W. J., Karoum F., Spoor H. E., Morihisa J. M., Olson L., Wyatt R. J. Catecholamine content of intracerebral adrenal medulla grafts. Brain Res. 1983 Jun 13;269(1):184–189. doi: 10.1016/0006-8993(83)90980-0. [DOI] [PubMed] [Google Scholar]
  38. Freed W. J., Ko G. N., Niehoff D. L., Kuhar M. J., Hoffer B. J., Olson L., Cannon-Spoor H. E., Morihisa J. M., Wyatt R. J. Normalization of spiroperidol binding in the denervated rat striatum by homologous grafts of substantia nigra. Science. 1983 Nov 25;222(4626):937–939. doi: 10.1126/science.6635666. [DOI] [PubMed] [Google Scholar]
  39. Freed W. J., Morihisa J. M., Spoor E., Hoffer B. J., Olson L., Seiger A., Wyatt R. J. Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour. Nature. 1981 Jul 23;292(5821):351–352. doi: 10.1038/292351a0. [DOI] [PubMed] [Google Scholar]
  40. Freed W. J., Patel-Vaidya U., Geller H. M. Properties of PC12 pheochromocytoma cells transplanted to the adult rat brain. Exp Brain Res. 1986;63(3):557–566. doi: 10.1007/BF00237478. [DOI] [PubMed] [Google Scholar]
  41. Freed W. J., Perlow M. J., Karoum F., Seiger A., Olson L., Hoffer B. J., Wyatt R. J. Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: long-term behavioral, biochemical, and histochemical studies. Ann Neurol. 1980 Nov;8(5):510–519. doi: 10.1002/ana.410080508. [DOI] [PubMed] [Google Scholar]
  42. Freund T. F., Bolam J. P., Björklund A., Stenevi U., Dunnett S. B., Powell J. F., Smith A. D. Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study. J Neurosci. 1985 Mar;5(3):603–616. doi: 10.1523/JNEUROSCI.05-03-00603.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Gage F. H., Björklund A., Stenevi U., Dunnett S. B., Kelly P. A. Intrahippocampal septal grafts ameliorate learning impairments in aged rats. Science. 1984 Aug 3;225(4661):533–536. doi: 10.1126/science.6539949. [DOI] [PubMed] [Google Scholar]
  44. Gage F. H., Wolff J. A., Rosenberg M. B., Xu L., Yee J. K., Shults C., Friedmann T. Implantation of genetically engineered cells to the brain. Prog Brain Res. 1988;78:651–658. doi: 10.1016/s0079-6123(08)60345-3. [DOI] [PubMed] [Google Scholar]
  45. Goetz C. G., Olanow C. W., Koller W. C., Penn R. D., Cahill D., Morantz R., Stebbins G., Tanner C. M., Klawans H. L., Shannon K. M. Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med. 1989 Feb 9;320(6):337–341. doi: 10.1056/NEJM198902093200601. [DOI] [PubMed] [Google Scholar]
  46. Graham D. G., Tiffany S. M., Bell W. R., Jr, Gutknecht W. F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol. 1978 Jul;14(4):644–653. [PubMed] [Google Scholar]
  47. Hansen J. T., Kordower J. H., Fiandaca M. S., Jiao S. S., Notter M. F., Gash D. M. Adrenal medullary autografts into the basal ganglia of Cebus monkeys: graft viability and fine structure. Exp Neurol. 1988 Oct;102(1):65–75. doi: 10.1016/0014-4886(88)90079-9. [DOI] [PubMed] [Google Scholar]
  48. Hargraves R., Freed W. J. Chronic intrastriatal dopamine infusions in rats with unilateral lesions of the substantia nigra. Life Sci. 1987 Mar 9;40(10):959–966. doi: 10.1016/0024-3205(87)90315-8. [DOI] [PubMed] [Google Scholar]
  49. Hefti F., Hartikka J., Schlumpf M. Implantation of PC12 cells into the corpus striatum of rats with lesions of the dopaminergic nigrostriatal neurons. Brain Res. 1985 Dec 2;348(2):283–288. doi: 10.1016/0006-8993(85)90446-9. [DOI] [PubMed] [Google Scholar]
  50. Herman J. P., Choulli K., Geffard M., Nadaud D., Taghzouti K., Le Moal M. Reinnervation of the nucleus accumbens and frontal cortex of the rat by dopaminergic grafts and effects on hoarding behavior. Brain Res. 1986 May 7;372(2):210–216. doi: 10.1016/0006-8993(86)91127-3. [DOI] [PubMed] [Google Scholar]
  51. Herman J. P., Choulli K., Le Moal M. Activation of striatal dopaminergic grafts by haloperidol. Brain Res Bull. 1985 Dec;15(6):543–546. doi: 10.1016/0361-9230(85)90202-3. [DOI] [PubMed] [Google Scholar]
  52. Hitchcock E. R., Clough C., Hughes R., Kenny B. Embryos and Parkinson's disease. Lancet. 1988 Jun 4;1(8597):1274–1274. doi: 10.1016/s0140-6736(88)92088-0. [DOI] [PubMed] [Google Scholar]
  53. Isacson O., Brundin P., Kelly P. A., Gage F. H., Björklund A. Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum. Nature. 1984 Oct 4;311(5985):458–460. doi: 10.1038/311458a0. [DOI] [PubMed] [Google Scholar]
  54. Isacson O., Dunnett S. B., Björklund A. Graft-induced behavioral recovery in an animal model of Huntington disease. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2728–2732. doi: 10.1073/pnas.83.8.2728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Itakura T., Kamei I., Nakai K., Naka Y., Nakakita K., Imai H., Komai N. Autotransplantation of the superior cervical ganglion into the brain. A possible therapy for Parkinson's disease. J Neurosurg. 1988 Jun;68(6):955–959. doi: 10.3171/jns.1988.68.6.0955. [DOI] [PubMed] [Google Scholar]
  56. Jaeger C. B. Morphological and immunocytochemical characteristics of PC12 cell grafts in rat brain. Ann N Y Acad Sci. 1987;495:334–350. doi: 10.1111/j.1749-6632.1987.tb23684.x. [DOI] [PubMed] [Google Scholar]
  57. Jiao S. S., Zhang W. C., Cao J. K., Zhang Z. M., Wang H., Ding M. C., Zhang Z., Sun J. B., Sun Y. C., Shi M. T. Study of adrenal medullary tissue transplantation to striatum in parkinsonism. Prog Brain Res. 1988;78:575–580. doi: 10.1016/s0079-6123(08)60333-7. [DOI] [PubMed] [Google Scholar]
  58. Kish S. J., Morito C., Hornykiewicz O. Glutathione peroxidase activity in Parkinson's disease brain. Neurosci Lett. 1985 Aug 5;58(3):343–346. doi: 10.1016/0304-3940(85)90078-3. [DOI] [PubMed] [Google Scholar]
  59. Langston J. W., Irwin I., Langston E. B., Forno L. S. 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci Lett. 1984 Jul 13;48(1):87–92. doi: 10.1016/0304-3940(84)90293-3. [DOI] [PubMed] [Google Scholar]
  60. Lindvall O., Backlund E. O., Farde L., Sedvall G., Freedman R., Hoffer B., Nobin A., Seiger A., Olson L. Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Ann Neurol. 1987 Oct;22(4):457–468. doi: 10.1002/ana.410220403. [DOI] [PubMed] [Google Scholar]
  61. Lindvall O., Barry D. I., Kikvadze I., Brundin P., Bolwig T. G., Björklund A. Intracerebral grafting of fetal noradrenergic locus coeruleus neurons: evidence for seizure suppression in the kindling model of epilepsy. Prog Brain Res. 1988;78:79–86. doi: 10.1016/s0079-6123(08)60269-1. [DOI] [PubMed] [Google Scholar]
  62. Low W. C., Lewis P. R., Bunch S. T., Dunnett S. B., Thomas S. R., Iversen S. D., Björklund A., Stenevi U. Function recovery following neural transplantation of embryonic septal nuclei in adult rats with septohippocampal lesions. Nature. 1982 Nov 18;300(5889):260–262. doi: 10.1038/300260a0. [DOI] [PubMed] [Google Scholar]
  63. Lund R. D., Rao K., Hankin M. H., Kunz H. W., Gill T. J., 3rd Transplantation of retina and visual cortex to rat brains of different ages. Maturation, connection patterns, and immunological consequences. Ann N Y Acad Sci. 1987;495:227–241. doi: 10.1111/j.1749-6632.1987.tb23678.x. [DOI] [PubMed] [Google Scholar]
  64. Madrazo I., Drucker-Colín R., Díaz V., Martínez-Mata J., Torres C., Becerril J. J. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N Engl J Med. 1987 Apr 2;316(14):831–834. doi: 10.1056/NEJM198704023161402. [DOI] [PubMed] [Google Scholar]
  65. Madrazo I., León V., Torres C., Aguilera M. C., Varela G., Alvarez F., Fraga A., Drucker-Colín R., Ostrosky F., Skurovich M. Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease. N Engl J Med. 1988 Jan 7;318(1):51–51. doi: 10.1056/NEJM198801073180115. [DOI] [PubMed] [Google Scholar]
  66. Mahalik T. J., Finger T. E., Stromberg I., Olson L. Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft and host interconnections. J Comp Neurol. 1985 Oct 1;240(1):60–70. doi: 10.1002/cne.902400105. [DOI] [PubMed] [Google Scholar]
  67. Mason D. W., Charlton H. M., Jones A. J., Lavy C. B., Puklavec M., Simmonds S. J. The fate of allogeneic and xenogeneic neuronal tissue transplanted into the third ventricle of rodents. Neuroscience. 1986 Nov;19(3):685–694. doi: 10.1016/0306-4522(86)90292-7. [DOI] [PubMed] [Google Scholar]
  68. Mason P., Strassman A., Maciewicz R. Serotonin immunocytochemistry of physiologically characterized raphe magnus neurons. Exp Brain Res. 1988;73(1):1–7. doi: 10.1007/BF00279654. [DOI] [PubMed] [Google Scholar]
  69. Melamed E. Initiation of levodopa therapy in parkinsonian patients should be delayed until the advanced stages of the disease. Arch Neurol. 1986 Apr;43(4):402–405. doi: 10.1001/archneur.1986.00520040080025. [DOI] [PubMed] [Google Scholar]
  70. Morihisa J. M., Nakamura R. K., Freed W. J., Mishkin M., Wyatt R. J. Adrenal medulla grafts survive and exhibit catecholamine-specific fluorescence in the primate brain. Exp Neurol. 1984 Jun;84(3):643–653. doi: 10.1016/0014-4886(84)90211-5. [DOI] [PubMed] [Google Scholar]
  71. Patel-Vaidya U., Wells M. R., Freed W. J. Survival of dissociated adrenal chromaffin cells of rat and monkey transplanted into rat brain. Cell Tissue Res. 1985;240(2):281–285. doi: 10.1007/BF00222336. [DOI] [PubMed] [Google Scholar]
  72. Penn R. D., Goetz C. G., Tanner C. M., Klawans H. L., Shannon K. M., Comella C. L., Witt T. R. The adrenal medullary transplant operation for Parkinson's disease: clinical observations in five patients. Neurosurgery. 1988 Jun;22(6 Pt 1):999–1004. doi: 10.1227/00006123-198806010-00004. [DOI] [PubMed] [Google Scholar]
  73. Perlow M. J., Freed W. J., Hoffer B. J., Seiger A., Olson L., Wyatt R. J. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science. 1979 May 11;204(4393):643–647. doi: 10.1126/science.571147. [DOI] [PubMed] [Google Scholar]
  74. Perry T. L., Yong V. W. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett. 1986 Jun 30;67(3):269–274. doi: 10.1016/0304-3940(86)90320-4. [DOI] [PubMed] [Google Scholar]
  75. Peterson D. I., Price M. L., Small C. S. Autopsy findings in a patient who had an adrenal-to-brain transplant for Parkinson's disease. Neurology. 1989 Feb;39(2 Pt 1):235–238. doi: 10.1212/wnl.39.2.235. [DOI] [PubMed] [Google Scholar]
  76. Pezzoli G., Fahn S., Dwork A., Truong D. D., de Yebenes J. G., Jackson-Lewis V., Herbert J., Cadet J. L. Non-chromaffin tissue plus nerve growth factor reduces experimental parkinsonism in aged rats. Brain Res. 1988 Sep 6;459(2):398–403. doi: 10.1016/0006-8993(88)90659-2. [DOI] [PubMed] [Google Scholar]
  77. Riederer P., Wuketich S. Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis. J Neural Transm. 1976;38(3-4):277–301. doi: 10.1007/BF01249445. [DOI] [PubMed] [Google Scholar]
  78. Rose G., Gerhardt G., Strömberg I., Olson L., Hoffer B. Monoamine release from dopamine-depleted rat caudate nucleus reinnervated by substantia nigra transplants: an in vivo electrochemical study. Brain Res. 1985 Aug 19;341(1):92–100. doi: 10.1016/0006-8993(85)91476-3. [DOI] [PubMed] [Google Scholar]
  79. Schmidt R. H., Björklund A., Stenevi U., Dunnett S. B., Gage F. H. Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism. Acta Physiol Scand Suppl. 1983;522:19–28. [PubMed] [Google Scholar]
  80. Sladek J. R., Jr, Collier T. J., Haber S. N., Roth R. H., Redmond D. E., Jr Survival and growth of fetal catecholamine neurons transplanted into primate brain. Brain Res Bull. 1986 Dec;17(6):809–818. doi: 10.1016/0361-9230(86)90092-4. [DOI] [PubMed] [Google Scholar]
  81. Sladek J. R., Jr, Redmond D. E., Jr, Collier T. J., Blount J. P., Elsworth J. D., Taylor J. R., Roth R. H. Fetal dopamine neural grafts: extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys. Prog Brain Res. 1988;78:497–506. doi: 10.1016/s0079-6123(08)60323-4. [DOI] [PubMed] [Google Scholar]
  82. Spencer P. S., Nunn P. B., Hugon J., Ludolph A. C., Ross S. M., Roy D. N., Robertson R. C. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science. 1987 Jul 31;237(4814):517–522. doi: 10.1126/science.3603037. [DOI] [PubMed] [Google Scholar]
  83. Strecker R. E., Sharp T., Brundin P., Zetterström T., Ungerstedt U., Björklund A. Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis. Neuroscience. 1987 Jul;22(1):169–178. doi: 10.1016/0306-4522(87)90207-7. [DOI] [PubMed] [Google Scholar]
  84. Strömberg I., Almqvist P., Bygdeman M., Finger T. E., Gerhardt G., Granholm A. C., Mahalik T. J., Seiger A., Hoffer B., Olson L. Intracerebral xenografts of human mesencephalic tissue into athymic rats: immunochemical and in vivo electrochemical studies. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8331–8334. doi: 10.1073/pnas.85.21.8331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Strömberg I., Bygdeman M., Goldstein M., Seiger A., Olson L. Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: evidence for functional reinnervation. Neurosci Lett. 1986 Nov 21;71(3):271–276. doi: 10.1016/0304-3940(86)90632-4. [DOI] [PubMed] [Google Scholar]
  86. Strömberg I., Herrera-Marschitz M., Hultgren L., Ungerstedt U., Olson L. Adrenal medullary implants in the dopamine-denervated rat striatum. I. Acute catecholamine levels in grafts and host caudate as determined by HPLC-electrochemistry and fluorescence histochemical image analysis. Brain Res. 1984 Apr 9;297(1):41–51. doi: 10.1016/0006-8993(84)90541-9. [DOI] [PubMed] [Google Scholar]
  87. Strömberg I., Herrera-Marschitz M., Ungerstedt U., Ebendal T., Olson L. Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior. Exp Brain Res. 1985;60(2):335–349. doi: 10.1007/BF00235929. [DOI] [PubMed] [Google Scholar]
  88. Strömberg I., Johnson S., Hoffer B., Olson L. Reinnervation of dopamine-denervated striatum by substantia nigra transplants: immunohistochemical and electrophysiological correlates. Neuroscience. 1985 Apr;14(4):981–990. doi: 10.1016/0306-4522(85)90270-2. [DOI] [PubMed] [Google Scholar]
  89. Wallenburg H. C., Dekker G. A., Makovitz J. W., Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet. 1986 Jan 4;1(8471):1–3. doi: 10.1016/s0140-6736(86)91891-x. [DOI] [PubMed] [Google Scholar]
  90. Wictorin K., Isacson O., Fischer W., Nothias F., Peschanski M., Björklund A. Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum--I. Subcortical afferents. Neuroscience. 1988 Nov;27(2):547–562. doi: 10.1016/0306-4522(88)90288-6. [DOI] [PubMed] [Google Scholar]
  91. Widner H., Brundin P. Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis. Brain Res. 1988 Nov;472(3):287–324. doi: 10.1016/0165-0173(88)90010-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Wuerthele S. M., Freed W. J., Olson L., Morihisa J., Spoor L., Wyatt R. J., Hoffer B. J. Effect of dopamine agonists and antagonists on the electrical activity of substantia nigra neurons transplanted into the lateral ventricle of the rat. Exp Brain Res. 1981;44(1):1–10. doi: 10.1007/BF00238743. [DOI] [PubMed] [Google Scholar]
  93. Zetterström T., Brundin P., Gage F. H., Sharp T., Isacson O., Dunnett S. B., Ungerstedt U., Björklund A. In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis. Brain Res. 1986 Jan 8;362(2):344–349. doi: 10.1016/0006-8993(86)90460-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES